Rhaeos (Evanston, Ill.) won the competition and $350,000 grand prize in a virtual live audience vote at The Virtual MedTech Conference, powered by AdvaMed. The 2-year-old company’s wearable, noninvasive Flowsense device monitors ventricular shunt function for hydrocephalus patients — something which has required hospital visits for an MRI or CT scan to determine whether the tubes are properly draining excess spinal fluid from the brain.
“Participating in the MedTech Innovator Accelerator program has provided our team with invaluable mentorship and support from industry leaders that we are incredibly thankful for,” said Anna Lisa Somera, CEO of Rhaeos. “We are honored to be recognized by the medtech community as this year’s MedTech Innovator winner and we look forward to taking our next steps as a company to bring our solution to the patients who need it.”
Rhaeos beat out over 1,000 other startups and emerging-growth medical technology companies.
Cellvie, Circadia Health, Lief Therapeutics, and Moray Medical were runners-up and received a prize of $25,000 as finalists selected from this year’s MedTech Innovator Accelerator program.
